Neuroendocrine tumor (NET) disease is both rare and complex. About 15,000 new patients are diagnosed each year in the U.S. – which means many medical professionals will encounter neuroendocrine tumors only a few times in their careers.

The North American Neuroendocrine Tumor Society (NANETS) is a society of over 400 multidisciplinary medical professionals committed to the support of colleagues in diagnosing and treating NET patients, as well as furthering the cause of NET science and education in North America. With new research, technologies and practices emerging, the landscape of NET treatment is rapidly changing.

We invite you to the 2021 Multidisciplinary NET Medical Symposium (Nov. 4-6) in Chicago. In addition to continuing education accredited sessions, this symposium includes presentations on cutting-edge NET research in interactive sessions, special poster sessions, young investigator presentations, an early career track and a comprehensive allied health track. NANETS' annual grant awards are announced each year at this symposium. Learn more about submitting for NANETS annual grant awards.

Covid Statement:
NANETS is carefully monitoring developments related to the Covid-19 virus and following the recommendations of the Chicago Department of Health. Should cases continue to increase, NANETS may require proof of vaccination, a negative covid test, and/or masks to be required by participants. Please continue to visit our website and watch your email for the latest information about requirements for this year's NET Medical Symposium.